drugset / Trial / NCT03472846
MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis
Non-randomizedCrossoverOpen-labelDiagnostic
Summary
The aim of this study is the quantitative determination of bone-specific microRNAs in the serum of postmenopausal women with osteoporosis during antiresorptive or osteoanabolic therapy.
Timeline
- Start
- 2017-03-01
- Primary completion
- 2022-09-01
- Completion
- 2022-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Denosumab | Monoclonal antibody | 60 mg/ml | Subcutaneous |
| Comparator | Teriparatide | Protein / enzyme biologic | — | — |